Press Releases

13 Jan 2025

NUS Medicine study: Brain connectome phenotype linked to cerebrovascular disease can track cognitive decline

Researchers have uncovered novel insights into how brain function disruptions related to cerebrovascular disease (CeVD) interact with Alzheimer’s disease (AD) pathology to impact neurodegeneration and cognition in older adults. Led by Associate Professor Juan Helen Zhou, Director of the Centre for Translational Magnetic Resonance Research, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), the research team revealed a brain functional connectome phenotype that is related to multiple CeVD markers and contributes additively to cognitive decline and neurodegeneration alongside AD. The study highlights CeVD as a global disruptor of brain connectivity, reshaping our understanding of its role in dementia.

09 Jan 2025

Official Launch of Global Heat Health Information Network Southeast Asia Hub at NUS Medicine

The GHHIN Southeast Asia Hub was launched at the first GHHIN Southeast Asia Heat Health Forum, a four-day forum that will serve as a pivotal platform for fostering partnerships, advancing evidence-based policies to manage extreme heat risks effectively in the region, and enhancing the region’s collective capacity to protect lives and livelihoods.

03 Jan 2025

NUS Medicine students bring hearing care to Cambodian villagers

Students working on Project Battambang as part of NUS Medicine’s Health, Humanitarian & Leadership (HHL) Programme collaborated with audiologists from WS Audiology, a global leader in the hearing aid industry, to conduct vital health screenings that included for the first time, professional hearing assessments for villagers in Poipet, Cambodia.

19 Dec 2024

NUS Medicine researchers unveil NeuroAI-powered analytical tool for early detection and diagnosis of brain disorders

To improve our understanding of how different brain regions work together and develop better methods for analysing the complex, changing patterns of brain activity over time and space, researchers at the Yong Loo Lin School of Medicine (NUS Medicine) have unveiled a cutting-edge analytical tool designed for analysing brain dynamics, known as Brain-JEPA (Joint-Embedding Predictive Architecture).

19 Dec 2024

Bioengineered yeast microbes as targeted drug delivery systems

Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) have developed a groundbreaking way to engineer yeast (Saccharomyces cerevisiae) to create microbial communities that can perform complex tasks and self-regulate their composition in response to external signals.

13 Dec 2024

NUS Medicine's Vincenzo Sorrentino Joins EMBO Global Investigator Network to Advance Healthy Longevity Research

Research to focus on targeting the connection between mitochondria and proteostasis to extend healthspan.

19 Nov 2024

Singapore launches world’s first advanced degrees in sustainable healthcare for low-carbon healthcare future

Established by the Centre for Sustainable Medicine at the Yong Loo Lin School of Medicine, National University of Singapore, the world’s first Master’s programme in sustainable healthcare will address critical climate challenges, alongside a new Executive Fellowship for senior professionals. Applications are open today for the first batch of intake, set to begin in August 2025.

18 Nov 2024

NUS Medicine launches VK Rajah Professorship in Medical Ethics

Professorship honours former Attorney-General and Judge of Appeal

11 Nov 2024

Scientists use microcellular drones to deliver lung cancer killing drugs

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles (EVs) loaded with customisable anti-cancer antisense oligonucleotides suppressed cancer growth

25 Oct 2024

NUS study: Breastfeeding lowers cardiovascular risk in women with type 2 diabetes and gestational diabetes; lower gestational diabetes risk with healthy Mediterranean diet with low POP exposure

The Global Centre for Asian Women’s Health and Université Paris Cite are collaborating on initiatives based on modifiable risk factors such as nutrition, lifestyle and behaviours to influence women’s health outcomes across their life course and beyond.